AM

Amine Marouf

HealthTech investor

Paris, Île-de-France

Overview

Work Experience

  • Principal

    2017 - Current

    - Market watch, deal opportunities sourcing (800 per year), selection of opportunities. - Relationship management with: research centers, incubators, hospitals, startup studios in Healthcare in Europe. - Investment committees, jury member (iLab, Saclay Spring, SATT, EIT Health), speaker for national innovation programs and events (12 per year), board observer. - Investment: seed stage investments, 2 per year; investing 83M€ in Europe in digital health, medical diagnosis and monitoring, across all therapeutic areas

  • Board member & lead investor

    2020

  • Board member & lead investor

    2021

  • Expert France 2030

    2018

    Dans le cadre de la doctrine du plan France 2030, l’Etat a décidé depuis 2022 de généraliser la participation d’experts indépendants issus de la société civile à l’évaluation des dossiers déposés auprès d’appels à projets financés par les différents ministères: Au sein d’un jury composé d’autres experts indépendants et d’experts sectoriels Bpifrance, lecture, audition et évaluation de projets afin de statuer ou non sur leur pré-sélection.

  • Expert

    2023

  • Entrepreneur / Innovation Consultant

    2015

    Clients : start-up, Tech-transfert public offices Fields : Health, Life sciences, R&D Strategic foresight analysis, Start-up launching, Innovation events management

  • Expert & Jury member

    2018 - 2024

    i-Lab, i-Démo, i-Nov etc.

  • Board observer & co-investor

    2020 - 2023

  • Board observer & co-investor

    2020 - 2023

  • Consultant life sciences

    2017 - 2017

Relevant Websites